PUBLISHER: Grand View Research | PRODUCT CODE: 1611526
PUBLISHER: Grand View Research | PRODUCT CODE: 1611526
The global 3D medical imaging devices market is estimated to reach USD 20.31 billion by 2030, registering a CAGR of 8.11% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing prevalence of cardiovascular diseases, Alzheimer's, cancer, and other chronic diseases. Moreover, the rise in healthcare expenditure across developed economies and rapid technological advancements are some of the other factors responsible for the market growth.
Furthermore, continuous advancements in imaging technology play an important role in driving market growth. Innovations in modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound have led to higher-resolution 3D imaging, allowing for more precise and detailed visualization of anatomical structures and pathological conditions. Healthcare providers are increasingly seeking state-of-the-art imaging equipment, which fuels the demand for 3D medical imaging devices.
Competition among medical device manufacturers and the introduction of new and innovative 3D imaging devices are driving market growth as companies strive to offer cutting-edge solutions. For instance, in August 2023, GigXR, Inc. launched an application, XR Library, which is driven by INTRAVISION XR, as part of its immersive learning platform. This innovative application provides a comprehensive collection of 3D medical visuals derived from CT and MRI scans. Similarly, in September 2022, GE Healthcare received FDA authorization for its AIR Recon, an advanced 3D and motion-insensitive imaging applications. This development promises to enhance the overall quality of MRI images while providing a more enhanced experience for patients. These factors are further contributing to market growth.